tailieunhanh - Infection risks in multiple myeloma: A systematic review and meta-analysis of randomized trials from 2015 to 2019

Patients with multiple myeloma (MM) remain at an increased risk of infection due to the disease process, as well as the ensuing treatments. We performed a systematic review to evaluate the monthly risk of grade III/IV infection, pneumonia, and neutropenia in patients with myeloma enrolled in randomized clinical trials (RCTs). |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN